This study and publication charges were funded by Jazz Pharmaceuticals. All authors had full access to all of the data in this study and take complete responsibility for the integrity of the data and accuracy of the data analysis. Yejia Mao is acknowledged for statistical programming and graphical design. Under the direction of the authors, E. Jay Bienen, PhD, an employee of The Curry Rockefeller Group, LLC (CRG), provided medical writing assistance for this publication. Editorial assistance in formatting, proofreading, copy editing, and fact checking was also provided by CRG. Jazz Pharmaceuticals provided funding to CRG for support in writing and editing this manuscript. All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this manuscript, take responsibility for the integrity of the work as a whole, and have given final approval for the version to be published.
Dr. Bogan is a shareholder, a Board of Directors member, Chief Medical Officer, and an employee of SleepMed Inc; is a Board of Directors member for First Community Corporation, SC, and National Sleep Foundation; has received consultant fees from Aerial BioPharma, LLC, Jazz Pharmaceuticals, Inc., ApniCure, UCB, and Teva; has received industry-funded research support from Actelion, Boehringer Ingelheim, GSK, Jazz Pharmaceuticals, Inc., Vanda, Merck, Novo Nordisk, Pfizer, Schwarz, Sepracor, XenoPort, Eisai, Ventus, Philips, ResMed, ApniCure, Sensory Medical, J&J, Apnex, and Fisher Paykel; and has been a speakers’ bureau member for Teva, Jazz Pharmaceuticals, Inc., UCB, Vanda, Merck, and XenoPort. Dr Black is a part-time employee of Jazz Pharmaceuticals and shareholder of Jazz Pharmaceuticals plc. Dr. Swick is an employee of Neurology and Sleep Medicine Consultants; has received consultancy fees and/or honoraria from Jazz Pharmaceuticals, Vanda Pharmaceuticals, XenoPort Pharmaceuticals, UCB Pharma, Merck Pharma, Aerial BioPharma, LLC; has received research funding from Jazz Pharmaceuticals, Aerial BioPharma, LLC, GSK Pharmaceuticals, Otsuka Pharmaceuticals, Teva Pharmaceuticals, Vanda Pharmaceuticals; and is a speakers’ bureau member for Jazz Pharmaceuticals, XenoPort Pharmaceuticals, and UCB Pharma. Dr. Mamelak has received consultancy fees from Jazz Pharmaceuticals. Dr Kovacevic-Ristanovic has received honoraria as a speakers’ bureau member for Jazz Pharmaceuticals, Inc. Ms Villa is an employee of Jazz Pharmaceuticals who, in the course of this employment, has received stock options exercisable for, and other stock awards of, ordinary shares of Jazz Pharmaceuticals plc. Ms Mori is an employee of Jazz Pharmaceuticals who, in the course of this employment, has received stock options exercisable for, and other stock awards of, ordinary shares of Jazz Pharmaceuticals plc. Dr Montplaisir has received consultancy fees from Jazz Pharmaceuticals, Inc., Merck, UCB, and Valeant Pharmaceuticals; and has received research funding from GSK and Merck.
Compliance with Ethics Guidelines
This article does not contain any new studies with human or animal subjects performed by any of the authors.
This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.